Holen Sie sich die Stockscreener-App
6.90
2.13%
-0.15
Finanzdaten der Igm Biosciences Inc-Aktie (IGMS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
23.66%
0.497
|
0.651 | 0.509 | 0.448 | 0.522 |
Operating Expenses
|
17.36%
54.35
|
65.77 | 67.27 | 68.66 | 63.90 |
| Benefits Costs and Expenses |
17.66%
50.31
|
61.10 | 62.26 | 64.76 | 59.74 |
| Costs And Expenses |
17.36%
54.35
|
65.77 | 67.27 | 68.66 | 63.90 |
| Operating Income/Loss |
17.30%
-53.86
|
-65.12 | -66.76 | -68.21 | -63.37 |
| Nonoperating Income/Loss |
13.42%
4.04
|
4.666 | 5.011 | 3.894 | 4.152 |
| Income/Loss From Continuing Operations Before Tax |
17.60%
-49.82
|
-60.45 | -61.75 | -64.31 | -59.22 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.242 | 0.24 | 0.109 | 0.087 |
| Income/Loss From Continuing Operations After Tax |
17.92%
-49.82
|
-60.70 | -61.99 | -64.42 | -59.31 |
|
Net Income/Loss
|
17.92%
-49.82
|
-60.70 | -61.99 | -64.42 | -59.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,273%
60.11
|
2.5332 | 59.58 | 45.12 | 44.47 |
| Diluted Average Shares |
2,273%
60.11
|
2.5332 | 59.58 | 45.12 | 44.47 |
| Basic Earnings Per Share |
15.31%
-0.83
|
-0.98 | -1.04 | -1.43 | -1.33 |
| Diluted Earnings Per Share |
15.31%
-0.83
|
-0.98 | -1.04 | -1.43 | -1.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):